Paid Clinical Trials Augusta

Discover 234 paid clinical trials in Augusta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 234

DALY II USA/ MB-CART2019.1 for DLBCLDALY II USA/ MB-CART2019.1 for DLBCL

Recruiting

PHASE2

Sponsor:

Miltenyi Biomedicine GmbH

Location:

Augusta GA, Atlanta GA, Durham NC, Columbus OHshow 18 more

Code:

NCT04792489

Conditions

Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Relapsed Diffuse Large B Cell Lymphoma

High Grade B-cell Lymphoma (HGBCL)

Primary Mediastinal B-cell Lymphoma (PMBCL)

Transformed Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

zamtocabtagene autoleucel (MB-CART2019.1)

Cyclophosphamide

Fludarabine

Bendamustine

A Research Study to Advance the CF Therapeutics Pipeline for People Without ModulatorsA Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Recruiting

Sponsor:

Nicole Hamblett

Location:

Augusta GA, Columbia SC, Charleston SC, Atlanta GAshow 58 more

Code:

NCT06504589

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Augusta GA, Union SC, Spartanburg SC, Greer SCshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Study of ALXN2220 Versus Placebo in Adults With ATTR-CMStudy of ALXN2220 Versus Placebo in Adults With ATTR-CM

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Augusta GA, Greenville SC, Charleston SC, Atlanta GAshow 44 more

Code:

NCT06183931

Conditions

Transthyretin Amyloid Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ALXN2220

Placebo

Tocilizumab in SchizophreniaTocilizumab in Schizophrenia

Recruiting

PHASE1

Sponsor:

Brian Miller

Location:

Augusta GA

Code:

NCT02874573

Conditions

Schizophrenia

Psychotic Disorders

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Tocilizumab

Normal saline

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial CarcinomaSelinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Recruiting

PHASE3

Sponsor:

Karyopharm Therapeutics Inc

Location:

Augusta GA, Gainesville GA, Charlotte NC, Atlanta GAshow 71 more

Code:

NCT05611931

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selinexor

Matching Placebo for selinexor

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in AdultsTesting the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Augusta GA, Greenville SC, Easley SC, Seneca SCshow 142 more

Code:

NCT04530565

Conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Cytarabine

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Augusta GA, Charlotte NC, Atlanta GA, Marietta GAshow 67 more

Code:

NCT03486873

Conditions

Solid Tumors

Hematologic Malignancies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Standard of Care (SOC)

Lenvatinib

Olaparib

MK-4280

Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer PatientsStudy of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Augusta GA, Newnan GA, Birmingham AL, Lexington KYshow 101 more

Code:

NCT04310020

Conditions

Lung Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage III Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Biospecimen Collection

Computed Tomography

Hypofractionated Radiation Therapy

Magnetic Resonance Imaging

A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer PatientsA RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

Recruiting

Sponsor:

McMaster University

Location:

Augusta GA, London, Hamilton, Kitchenershow 9 more

Code:

NCT03127631

Conditions

Prostate Cancer

Cardiovascular Disease

Eligibility Criteria

Sex: Male

Age: 45+

Healthy Volunteers: Not accepted

Interventions

Nutrition

Exercise

Smoking cessation

Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin)

ACE inhibitor